P. Escudero

Phase II, Randomized Study of Concomitant Chemoradiotherapy Followed by Surgery and Adjuvant Capecitabine Plus Oxaliplatin (CAPOX) Compared With Induction CAPOX Followed by Concomitant Chemoradiotherapy and Surgery in Magnetic Resonance Imaging–Defined, Locally Advanced Rectal Cancer: Grupo Cáncer de Recto 3 Study

Carlos Fernández-Martos, Carles Pericay, Jorge Aparicio et al. · Journal of Clinical Oncology · 2010 · 428 citations · Full text

Adaptive Radiotherapy, Recto 3, Radiation Medicine +15

Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial

Carlos Fernández-Martos, Xabier García‐Albéniz, Carles Pericay et al. · Annals of Oncology · 2015 · 352 citations · Full text

Surgical Oncology, Radiation Therapy, Medicine +6

Deletions Affecting Codons 557-558 of the <i>c</i>-<i>KIT</i> Gene Indicate a Poor Prognosis in Patients With Completely Resected Gastrointestinal Stromal Tumors: A Study by the Spanish Group for Sarcoma Research (GEIS)

Javier Martín‐Broto, Andrés Poveda, Antonio Llombart‐Bosch et al. · Journal of Clinical Oncology · 2005 · 350 citations · Full text

First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

Eduardo Díaz‐Rubio, Auxiliadora Gómez‐España, Bartomeu Massutí et al. · The Oncologist · 2012 · 212 citations · Full text

Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)

Enrique Grande, Jaume Capdevila, Daniel Castellano et al. · Annals of Oncology · 2015 · 155 citations · Full text

Open-label Trial, Endocrine Oncology, Surgical Oncology +10